First in Central & Southeastern Ohio to Use Dissolving Heart Stent
Stent disappears completely in about 3 years
ZANESVILLE, OH (July 15, 2016) – The interventional cardiology team at Genesis Hospital recently became the first in Central and Southeastern Ohio to offer patients with coronary artery disease a new treatment option that literally disappears over time.
Abdulhay Albirini, M.D., FACC, interventional cardiologist with the Genesis Heart, Lung & Vascular Group, performed a procedure on a patient to implant the world’s first FDA-approved dissolving heart stent July 15, 2016. The stent, called Absorb, is a bioresorbable vascular scaffold device manufactured by Abbott Vascular. It is a major advancement in the treatment of coronary artery disease, which affects 15 million people in the U.S. and remains a leading cause of death worldwide despite decades of therapeutic advances.
“The Absorb stent opens clogged arteries to restore blood flow, then gradually dissolves in the body,” said Albirini. “It will reduce the risk of future cardiac events that can occur with metal stents. Patients with heart disease will benefit long-term from this kind of intervention.”
“Our interventional cardiology team underwent additional training on the new device,” added Albirini. “We are pleased to be the second hospital in the state of Ohio and among a few in the nation to provide this technologically advanced treatment to heart patients in our community.”
While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in about 3 years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants. Absorb dissolves except for two pairs of tiny metallic markers that remain in the artery to enable a physician to see where the device was placed.
Find out what else our heart and vascular team is doing to provide excellent care.